• IP 172162533 页面 用户名 密码

发布时间：2024-07-16

• Dolutegravir versus ritonavir

data-id="" iid="">PubMedhttps://pubmed.ncbi.nlm.nih.gov/30732940Dolutegravir versus ritonavir-boosted lopinavir both with …网页Because the lower bound of the 95% CI is greater than zero (7·3%), superiority of dolutegravir was also concluded (p<0·0001). The safety profile for dolutegravir was favourable compared with that of ritonavir-boosted lopinavir.

发布时间：2024-07-16

• Effectiveness of self

data-id="" iid="">PubMedhttps://pubmed.ncbi.nlm.nih.gov/36260465Effectiveness of self-designed dental storybook as behavior ...网页Self-designed dental storybook as an adjuvant was found to be promising behavior modification technique for 57-year-old children.

发布时间：2024-07-16

• Ping 在线工具 Wired Blade

发布时间：2024-07-16

• 常州天马集团有限公司原建材二五三厂

发布时间：2024-07-16

• 网中网财务实训平台

发布时间：2024-07-16

• IP

发布时间：2024-07-16

• Risk factors in clinically diagnosed presenile dementia of the

data-id="" iid="">PubMedhttps://pubmed.ncbi.nlm.nih.gov/7629459Risk factors in clinically diagnosed presenile dementia of the ...网页In this study of modest statistical power, a family history of dementia was confirmed as a risk factor in PDAT. No significant relationship between exposure to aluminium in water supplies, tea, and antacids was found. What is important, however, is the bioavailability of all dietary aluminium, deter …

发布时间：2024-07-16

• Biological therapies for myasthenia gravis

data-id="" iid="">PubMedhttps://pubmed.ncbi.nlm.nih.gov/36852951Biological therapies for myasthenia gravis - PubMed网页Several biological therapies have been developed for MG, and these biologics are promising agents for treating refractory MG. Establishing biomarkers and accumulating evidence of therapeutic response is required to provide the most …

发布时间：2024-07-16